How Much Does Vardenafil (Levitra/Staxyn) Cost in Virginia in 2026?

Virginia Retail Pharmacy Prices for Vardenafil in 2026

The average cash-pay price for generic vardenafil across Virginia retail pharmacies sits around $120 per month in 2026, based on a standard supply of eight to ten 20 mg tablets. Brand-name Levitra, manufactured by Bayer, carries a list price near $350 per month. Staxyn (the orally disintegrating formulation) typically costs more than generic tablets.

Price variation across Virginia is real. A CVS or Walgreens in Northern Virginia may quote $12 to $18 per tablet for generic vardenafil, while independent pharmacies in Richmond or Virginia Beach sometimes price closer to $8 per tablet. The FDA approved vardenafil (Levitra) in 2003 as the second PDE5 inhibitor after sildenafil 1. That original approval was supported by key trials showing significant erectile function improvement across severity groups 2. Generic entry after 2018 cut costs substantially, but prices still vary by pharmacy, so comparison shopping matters.

GoodRx, RxSaver, and similar discount platforms can reduce the per-tablet cost to $4 to $9 at participating Virginia pharmacies. These free coupons work at chains and independents alike and require no insurance. For men filling prescriptions regularly, this discount layer often represents the single largest savings opportunity.

Brand Levitra vs. Generic Vardenafil: What Virginia Patients Pay

Brand Levitra is rarely dispensed in Virginia today. Generic vardenafil hydrochloride tablets are therapeutically equivalent (FDA "AB" rated), meaning they deliver the same active compound at the same dose with the same bioavailability 3. Pharmacists in Virginia will automatically substitute the generic unless the prescriber writes "dispense as written."

The practical cost difference is stark. Brand Levitra: roughly $35 per tablet. Generic vardenafil: $8 to $15 without discount tools, $4 to $9 with them. Staxyn, the orally disintegrating tablet formulation approved in 2010, has no generic equivalent as of mid-2026 and typically runs $30 to $45 per tablet cash-pay in Virginia 4. Unless a patient specifically needs the dissolving tablet (useful for men who have difficulty swallowing), generic vardenafil tablets offer the same clinical benefit at a fraction of the price.

Porst et al. demonstrated in a randomized controlled trial (N=580) that vardenafil 20 mg improved the erectile function domain score of the International Index of Erectile Function (IIEF) by 9.3 points versus 3.7 for placebo (P<0.001) 2. That efficacy profile is identical regardless of whether a patient fills the brand or generic product.

Virginia Medicaid Coverage for Vardenafil

Virginia Medicaid does cover vardenafil, but prior authorization is required. The PA process exists because the Virginia Department of Medical Assistance Services (DMAS) classifies PDE5 inhibitors as non-preferred agents requiring clinical documentation. To obtain approval, the prescribing clinician must document a diagnosis of erectile dysfunction and, in some cases, demonstrate that the patient has tried or has a contraindication to a preferred alternative.

The American Urological Association (AUA) guidelines recognize all PDE5 inhibitors (sildenafil, tadalafil, vardenafil, and avanafil) as first-line pharmacotherapy for ED 5. Virginia Medicaid aligns with this class-level recommendation but uses PA to manage utilization. Approval typically covers six to eight tablets per month.

For Virginia Medicaid managed care enrollees (most Medicaid recipients in Virginia are in MCOs like Aetna Better Health, Anthem HealthKeepers, or Molina), the PA criteria may differ slightly by plan. Calling the number on the back of the Medicaid card or asking the prescriber's office to submit the PA electronically through the plan's portal is the fastest path. Turnaround is usually 24 to 72 hours. If denied, Virginia law guarantees an appeal process 6.

Does Private Insurance Cover Vardenafil in Virginia?

Coverage varies by carrier and plan tier. Many Virginia employer-sponsored plans and ACA marketplace plans do include PDE5 inhibitors, though often with restrictions. Common patterns include quantity limits (four to eight tablets per month), step therapy requirements (try sildenafil first), and prior authorization.

The three largest commercial insurers in Virginia (Anthem Blue Cross Blue Shield, CareFirst, and Optima Health) each handle vardenafil differently on their formularies. Anthem plans frequently tier generic vardenafil at Tier 2 or Tier 3, producing copays of $20 to $50 for a 30-day supply. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy notes that ED treatment, including PDE5 inhibitors, should be addressed as part of comprehensive male hypogonadism management 7. That guideline statement can support medical necessity letters when insurers require justification.

Federal Employee Health Benefits (FEHB) plans, which cover a large population in Northern Virginia near D.C., tend to provide more consistent PDE5 inhibitor coverage. TRICARE, serving Virginia's substantial military-connected community, covers generic vardenafil with a Tier 2 copay at TRICARE Pharmacy network retailers 8.

Compounded Vardenafil in Virginia: Legality and Cost

Compounded vardenafil is legal in Virginia when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits this compounding pathway, and the Virginia Board of Pharmacy regulates these facilities at the state level 9.

Compounded formulations may include vardenafil combined with other agents (such as a vardenafil-tadalafil combination troche or a sublingual rapid-dissolve tablet). Pricing from 503A pharmacies varies, but compounded vardenafil-containing formulations often run $2 to $6 per dose, significantly below retail generic pricing. Some telehealth platforms operating in Virginia partner directly with 503A compounding pharmacies to offer bundled pricing that includes the consultation, prescription, and medication.

One clinical consideration: compounded drugs are not FDA-approved finished products. The FDA has stated that compounded drugs "are not evaluated for safety, effectiveness, or quality" in the same manner as commercially manufactured drugs 9. Patients should verify that their compounding pharmacy holds current Virginia Board of Pharmacy accreditation and ideally carries PCAB (Pharmacy Compounding Accreditation Board) certification. A 2020 study published in JAMA Internal Medicine found measurable potency variability in compounded medications, reinforcing the importance of pharmacy selection 10.

Telehealth Prescribing of Vardenafil in Virginia

Virginia permits telehealth prescribing of vardenafil. The state's telehealth parity laws, expanded permanently after the temporary COVID-era flexibilities, allow licensed clinicians to evaluate, diagnose, and prescribe ED medications through synchronous audio-video visits. An in-person exam is not required for PDE5 inhibitor prescriptions in Virginia provided the clinician conducts an adequate history and assessment 11.

Multiple national telehealth platforms serve Virginia patients for ED treatment. The typical workflow: complete a health questionnaire, have a video or asynchronous consultation with a Virginia-licensed provider, and receive a prescription sent to your pharmacy of choice or to a partner mail-order pharmacy. Costs for the telehealth visit itself range from $0 (bundled with medication purchase) to $75 for a standalone consultation.

The AUA's 2018 guideline on ED notes that patient evaluation should include a thorough medical and sexual history, with physical examination performed "when indicated" 5. This language supports the telehealth model for straightforward ED cases in men without red-flag symptoms such as penile deformity, recent pelvic surgery, or unstable cardiovascular disease. Men with those findings should be evaluated in person.

How to Save the Most on Vardenafil in Virginia

Several strategies stack to minimize out-of-pocket cost.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare coupons are accepted at nearly all Virginia chain and independent pharmacies. These can bring generic vardenafil below $5 per tablet at Costco, Walmart, or select independents. A 2023 analysis in the Journal of General Internal Medicine found that discount card prices beat insurance copays for generic medications in roughly 10% to 18% of fills 12.

Manufacturer copay cards. Bayer has periodically offered savings cards for brand Levitra, though availability in 2026 should be confirmed directly at the Bayer website or through the prescribing provider. These cards typically reduce the brand copay by $10 to $40 per fill for commercially insured patients and cannot be used with Medicaid or other government insurance per federal anti-kickback statute restrictions 13.

Pill splitting. Generic vardenafil 20 mg tablets are scored. Prescribers can write for 20 mg tablets with instructions to split, effectively halving the per-dose cost for patients whose effective dose is 10 mg. The FDA notes that pill splitting is acceptable for scored tablets when done with a proper pill splitter 14. This is a well-established cost-reduction technique that a meta-analysis of PDE5 inhibitor utilization studies has validated as clinically appropriate 15.

90-day mail order. Many Virginia insurance plans and discount programs offer lower per-unit pricing for 90-day supplies through mail-order pharmacies. Express Scripts, CVS Caremark, and Optum Rx all serve Virginia residents.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of manufacturer and independent charity programs. Uninsured Virginia patients with household income below 200% to 400% of the federal poverty level may qualify for free or reduced-cost medication through these channels.

Clinical Considerations for Virginia Patients

Vardenafil is dosed on-demand, taken 30 to 60 minutes before anticipated sexual activity. The recommended starting dose is 10 mg, with adjustment to 5 mg or 20 mg based on efficacy and tolerability 1. Maximum dosing frequency is once per 24 hours.

Vardenafil carries a specific contraindication with QT-prolonging medications due to a modest effect on the QTc interval, a distinction from sildenafil and tadalafil 16. Virginia prescribers should review the patient's medication list for Class IA and Class III antiarrhythmics (quinidine, procainamide, amiodarone, sotalol) before prescribing. Concomitant nitrate use remains an absolute contraindication across all PDE5 inhibitors per the ACC/AHA consensus statement on sexual activity and cardiovascular disease 17.

Common side effects include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%), based on pooled trial data 2. These are generally mild and transient. The Porst et al. trial reported a discontinuation rate due to adverse events of only 3.4% for vardenafil 20 mg versus 1.7% for placebo, indicating good tolerability.

For men with diabetes-related ED, a specific population well-represented in Virginia's patient demographics, Goldstein et al. showed in a dedicated RCT (N=452) that vardenafil 20 mg improved IIEF-EF scores by 6.6 points versus 1.4 for placebo (P<0.001) 18. The ADA Standards of Care acknowledge PDE5 inhibitors as appropriate treatment for diabetic ED 19.

Vardenafil vs. Other PDE5 Inhibitors: Cost Comparison in Virginia

Virginia patients choosing among PDE5 inhibitors will find generic vardenafil competitively priced against generic sildenafil and generic tadalafil. Sildenafil (generic Viagra) is typically the cheapest option at $1 to $5 per tablet with discount cards, while generic tadalafil runs $3 to $10 per tablet. Generic vardenafil falls in the $4 to $9 range with coupons.

The clinical differentiation is pharmacokinetic. Vardenafil has a Tmax of approximately 60 minutes and a half-life of 4 to 5 hours, placing it between sildenafil (shorter onset, similar duration) and tadalafil (longer onset, 17.5-hour half-life) 1. A head-to-head crossover study by Rubio-Aurioles et al. (N=222) found no statistically significant difference in overall efficacy between vardenafil 20 mg and sildenafil 100 mg, but patient preference was split, with some men preferring one agent's side-effect profile over the other 20.

For Virginia patients who want the flexibility of daily dosing, tadalafil 5 mg daily is the only PDE5 inhibitor with that FDA-approved indication. Vardenafil remains on-demand only. The choice among agents should be individualized based on intercourse frequency, comorbidities, concomitant medications, and cost.